galderma sa americanswiss pharmaceutical company specializing dermatological treatments skin care products formerly subsidiary loréal nestlé held consortium private institutional investors since galderma formed joint venture nestlé loréal became subsidiary since belongs investment fund company headed president ceo flemming ørnskov exshire sites worldwide network distributors employs people headquarters based zug switzerland slogan galderma advancing dermatology every skin origins galderma date back founding owen dermatology company dallas texas usa professor hans schaefer founded international center dermatological research cird sophia antipolis support ceo loréal françois dalle wanted diversify cosmetic research drug sector time nestlé also ambitions dermatology bought owen laboratory loréal nestlé joined forces create galderma cird became galderma rd joint venture two galderma global corporate campaign medical marketing associations international award excellence sales reached billion euros increase needed galderma expanded specializing research development commercialization products dermatology skin care patients reached significant size subsidiaries present countries diversified aesthetic medicine products botulinum toxin azzalure field strengthened acquisition swedish medicaldevice company nestlé bought back shares loréal thus creating new unit nestlé group called nestle skin health transaction value billion billion paid nestlé million loréal loréal paid billion billion remaining million nestlé sold galderma consortium comprising eqt viii fund luxinva wholly owned subsidiary abu dhabi investment authority psp investments institutional investors since largest independent dermatology company november galderma bought californiabased alastin firm specialising specialist skincare products undisclosed june galderma announced positive results two phase iii trials liquid botulinum toxin showing relabotulinumtoxina significantly reduced frown line severity well tolerated result primes company apply approval us global also june galderma announced positive data phase iii trial showing efficacy safety nemolizumab patients prurigo nodularis nemolizumab monoclonal antibody blocks signaling neuroimmune cytokine involved pathogenesis prurigo galderma specialized research development commercialization skin care products treatments across aesthetics consumer care prescription medicine galderma provides range overthecounter prescription dermatological products skin care aesthetics treatment conditions including acne rosacea psoriasis steroidresponsive dermatoses srd onychomycosis fungal nail infections pigmentary disorders skin cancer skin aging galdermas activities divided three business units aesthetics consumer care prescription medicine galdermas products sold countries galderma ipsen signed licensing agreement distribution botulinum toxin dysport known azzalure european union improvement glabellar lines frown lines eyes million treatments performed united states european main brands restylane azzalure dysport alluzience sculptra galdermas products available overthecounter consumers main consumer care brands cetaphil range skin care products ages benzac differin otc mildtomoderate acne loceryl used treat fungal nail infections alastin disease areas atopic dermatitis dermatooncology psoriasis main brands aklief benzac cetaphil epiduo epiduo forte loceryl differin soolantra mirvaso oracea metvix company invests substantially research development sources new treatments activities partnerships others divides research development departments six sites galderma manufacturing facilities following locations httpsenwikipediaorgwikigalderma